Expansion of bone marrow adipocytes in obese mice leads to PD-L1-driven bone marrow immunosuppression and osteoclastogenesis

Abstract

Bone marrow adipocytes are known to have a critical role within the bone marrow niche. However, our understanding of bone marrow adipose tissue expansion with obesity and the role it plays in immune cell regulation and osteoclastogenesis is limited. Here, we showed the expansion of bone marrow adipocytes promoted osteoclast differentiation and subsequently led to obesity-related trabecular and cortical bone loss through a stimulatory effect of the PD-1/PD-L1 axis. Bone marrow adipocytes isolated from obese mice had increased Mcp-1 expression, a key regulator of osteoclastogenesis and myeloid cell accumulation. With the increase in bone marrow adipose tissue-derived Mcp-1, we found an increase in the number of PD-L1⁺ myeloid cells. While these cells inhibited activated T-cells, we found evidence of a stimulatory osteoclastogenic effect of PD-L1⁺ myeloid cells on PD-1-expressing osteoclast precursors. The inhibition of PD-1/PD-L1 signaling during early osteoclastogenesis prevented myeloid cell commitment and resulted in decreased cell fusion, supporting the role of PD-1/PD-L1 signaling in osteoclastogenesis. Using a bone marrow adipocyte depletion mouse model (BMAd-Pparg KO), we demonstrated that obese BMAd-Pparg KO mice had a reduced number of bone marrow PD-L1⁺ myeloid cells, accompanied by a decrease in PD-1⁺ osteoclast precursors. The reduction in these precursors resulted in fewer osteoclasts, subsequently leading to improved trabecular bone volume. Since osteoclasts are myeloid cell-derived, these results suggest that bone marrow adipocytes are critical for the commitment and differentiation of myeloid cells into osteoclasts. Targeting bone marrow adipogenesis could ameliorate enhanced osteoclastogenesis and provide a novel approach to treat obesity-related bone loss.

Obesity-induced expansion of BM adipocytes leads to PD-1/PD-L1-driven osteoclastogenesis and subsequent bone loss in obese, HFD-fed (OB-HFD) mice. After 12 weeks on a HFD, OB-HFD mice had a significant increase in BM adiposity and BMAT-derived Mcp-1 expression. The increase in BMAT-specific Mcp-1 expression was coupled with an increase in PD-1⁺ osteoclast (OC) precursors and PD-L1⁺ myeloid cells. In the context of obesity, the PD-1/PD-L1 axis has a stimulatory effect that enhances osteoclastogenesis and leads to trabecular and cortical bone loss. By depleting BM adipocytes with obesity, BMAT-derived Mcp-1 expression was decreased, as well as a decrease in PD-1⁺ OC precursors and PD-L1⁺ myeloid cells. This prevented obesity-related trabecular bone loss. Overall, this work demonstrated a strong correlation between BMAT expansion and PD-1/PD-L1-driven osteoclastogenesis as a mechanism for obesity-induced bone loss. (This image was created using BioRender).

[graphic not available: see fulltext]

References

[1] Islam ANMSet al. . The global burden of overweight-obesity and its association with economic status, benefiting from STEPs survey of WHO member states: a meta-analysis. Prev. Med. Rep.. 2024, 46. 102882

[2] Cao JJ. Effects of obesity on bone metabolism. J. Orthop. Surg. Res.. 2011, 6: 1-7.

[3] Gower BA, Casazza K. Divergent effects of obesity on bone health. J. Clin. Densitom.. 2013, 16: 450.

[4] Rinonapoli Get al. . Obesity and bone: a complex relationship. Int. J. Mol. Sci.. 2021, 2213662.

[5] Iwaniec UT, Turner RT. Influence of body weight on bone mass, architecture and turnover. J. Endocrinol.. 2016, 230R115-R130.

[6] Jensen VFH, Mølck AM, Dalgaard M, McGuigan FE, Akesson KE. Changes in bone mass associated with obesity and weight loss in humans: applicability of animal models. Bone. 2021, 145: 115781.

[7] Halade GV, El Jamali A, Williams PJ, Fajardo RJ, Fernandes G. Obesity-mediated inflammatory microenvironment stimulates osteoclastogenesis and bone loss in mice. Exp. Gerontol.. 2011, 4643-52.

[8] Tencerova Met al. . High-fat diet–induced obesity promotes expansion of bone marrow adipose tissue and impairs skeletal stem cell functions in mice. J. Bone Miner. Res.. 2018, 33: 1154-1165.

[9] Doucette CRet al. . A high fat diet increases bone marrow adipose tissue (MAT) but does not alter trabecular or cortical bone mass in C57BL/6J mice. J. Cell Physiol.. 2015, 230: 2032-2037.

[10] De Paula, F. J. A. & Rosen, C. J. Marrow adipocytes: origin, structure, and function. Annu. Rev. Physiol.82, 461–484 (2020).

[11] Suchacki, K. J., Cawthorn, W. P. & Rosen, C. J. Bone marrow adipose tissue: formation, function and regulation. Curr. Opin. Pharmacol.28, 50–56 (2016).

[12] Devlin, M. J. & Rosen, C. J. The bone-fat interface: basic and clinical implications of marrow adiposity. Lancet Diabetes Endocrinol.3, 141–147 (2015).

[13] Zhao, E. et al. Bone marrow and the control of immunity. Cell. Mol. Immunol.9, 11–19 (2012).

[14] Kawai T, Autieri MV, Scalia R. Adipose tissue inflammation and metabolic dysfunction in obesity. Am. J. Physiol. Cell Physiol.. 2021, 320: C375-C391.

[15] Man K, Kallies A, Vasanthakumar A. Resident and migratory adipose immune cells control systemic metabolism and thermogenesis. Cell. Mol. Immunol.. 2021, 19: 421-431.

[16] Nagareddy PRet al. . Adipose tissue macrophages promote myelopoiesis and monocytosis in obesity. Cell Metab.. 2014, 19: 821.

[17] Li Xet al. . Adipose tissue macrophages as potential targets for obesity and metabolic diseases. Front. Immunol.. 2023, 14. 1153915

[18] Surmi BK, Hasty AH. Macrophage infiltration into adipose tissue: initiation, propagation and remodeling. Future Lipidol.. 2008, 3545.

[19] Cronkite DA, Strutt TM. The regulation of inflammation by innate and adaptive lymphocytes. J. Immunol. Res.. 2018, 20181467538.

[20] Wang Ret al. . The interaction of innate immune and adaptive immune system. MedComm. 2024, 5. e714

[21] Andersen CJ, Murphy KE, Fernandez ML. Impact of obesity and metabolic syndrome on immunity. Adv. Nutr.. 2016, 766-75.

[22] Rius Bet al. . Resolution of inflammation in obesity-induced liver disease. Front. Immunol.. 2012, 3: 257.

[23] Painter SD, Ovsyannikova IG, Poland GA. The weight of obesity on the human immune response to vaccination. Vaccine. 2015, 334422.

[24] Shaikh SR, MacIver NJ, Beck MA. Obesity dysregulates the immune response to influenza infection and vaccination through metabolic and inflammatory mechanisms. Annu. Rev. Nutr.. 2022, 4267.

[25] Rohm TV, Meier DT, Olefsky JM, Donath MY. Inflammation in obesity, diabetes, and related disorders. Immunity. 2022, 5531-55.

[26] Singer Ket al. . Diet-induced obesity promotes myelopoiesis in hematopoietic stem cells. Mol. Metab.. 2014, 3: 664-675.

[27] Han Y, Liu D, Li L. PD-1/PD-L1 pathway: current researches in cancer. Am. J. Cancer Res.. 2020, 10: 727

[28] Li Wet al. . Correlation between PD-1/PD-L1 expression and polarization in tumor-associated macrophages: a key player in tumor immunotherapy. Cytokine Growth Factor Rev.. 2022, 6749-57.

[29] Lin Xet al. . Regulatory mechanisms of PD-1/PD-L1 in cancers. Mol. Cancer. 2024, 23: 1-50.

[30] Sun Yet al. . Macrophage-osteoclast associations: origin, polarization, and subgroups. Front. Immunol.. 2021, 12: 778078.

[31] Koza RAet al. . Changes in gene expression foreshadow diet-induced obesity in genetically identical mice. PLoS Genet.. 2006, 2e81.

[32] Yazbek SN, Spiezio SH, Nadeau JH, Buchner DA. Ancestral paternal genotype controls body weight and food intake for multiple generations. Hum. Mol. Genet.. 2010, 194134.

[33] Chusyd DE, Wang D, Huffman DM, Nagy TR. Relationships between rodent white adipose fat pads and human white adipose fat depots. Front. Nutr.. 2016, 3186521.

[34] Börgeson E, Boucher J, Hagberg CE. Of mice and men: pinpointing species differences in adipose tissue biology. Front. Cell Dev. Biol.. 2022, 101003118.

[35] Ellacott KLJ, Murphy JG, Marks DL, Cone RD. Obesity-induced inflammation in white adipose tissue is attenuated by loss of melanocortin-3 receptor signaling. Endocrinology. 2007, 1486186-6194.

[36] Chait A, den Hartigh LJ. Adipose tissue distribution, inflammation and its metabolic consequences, including diabetes and cardiovascular disease. Front. Cardiovasc. Med.. 2020, 7: 22.

[37] Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Elevated C-reactive protein levels in overweight and obese adults. JAMA. 1999, 2822131-2135.

[38] Yang RZet al. . Acute-phase serum amyloid A: an inflammatory adipokine and potential link between obesity and its metabolic complications. PLoS Med.. 2006, 3: 0884-0894.

[39] Weisberg SPet al. . Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest.. 2003, 112: 1796-1808.

[40] Amano SUet al. . Local proliferation of macrophages contributes to obesity-associated adipose tissue inflammation. Cell Metab.. 2014, 19: 162-171.

[41] Patsoukis N, Wang Q, Strauss L, Boussiotis VA. Revisiting the PD-1 pathway. Sci. Adv.. 2020, 6: eabd2712.

[42] Li Zet al. . Lipolysis of bone marrow adipocytes is required to fuel bone and the marrow niche during energy deficits. Elife. 2022, 11e78496.

[43] Li Zet al. . Constitutive bone marrow adipocytes suppress local bone formation. JCI Insight. 2022, 7. e160915

[44] Cao JJ, Gregoire BR, Gao H. High-fat diet decreases cancellous bone mass but has no effect on cortical bone mass in the tibia in mice. Bone. 2009, 441097-1104.

[45] Gautam Jet al. . Micro-architectural changes in cancellous bone differ in female and male C57BL/6 mice with high-fat diet-induced low bone mineral density. Br. J. Nutr.. 2014, 111: 1811-1821.

[46] Scheller ELet al. . Changes in skeletal integrity and marrow adiposity during high-fat diet and after weight loss. Front. Endocrinol.. 2016, 7: 102.

[47] Suresh S, Alvarez JC, Dey S, Noguchi CT. Erythropoietin-induced changes in bone and bone marrow in mouse models of diet-induced obesity. Int. J. Mol. Sci.. 2020, 211657.

[48] Song Wet al. . Obesity, but not high-fat diet, is associated with bone loss that is reversed via CD4⁺CD25⁺Foxp3⁺ Tregs-mediated gut microbiome of non-obese mice. npj Sci. Food. 2023, 71-14.

[49] Myers MG, Leibel RL, Seeley RJ, Schwartz MW. Obesity and leptin resistance: distinguishing cause from effect. Trends Endocrinol. Metab.. 2010, 21: 643.

[50] Costa SNet al. . Altered metabolomics and inflammatory transcriptomics in human bone marrow adipocytes after acute high calorie diet and acute fasting. Front. Endocrinol.. 2025, 16. 1591280

[51] Wan S, Xie J, Liang Y, Yu X. Pathological roles of bone marrow adipocyte-derived monocyte chemotactic protein-1 in type 2 diabetic mice. Cell Death Discov.. 2023, 9412.

[52] Ferland-McCollough Det al. . MCP-1 feedback loop between adipocytes and mesenchymal stromal cells causes fat accumulation and contributes to hematopoietic stem cell rarefaction in the bone marrow of patients with diabetes. Diabetes. 2018, 671380-1394.

[53] Miyamoto Ket al. . MCP-1 expressed by osteoclasts stimulates osteoclastogenesis in an autocrine/paracrine manner. Biochem. Biophys. Res. Commun.. 2009, 383: 373-377.

[54] Joseph GJ, Johnson DB, Johnson RW. Immune checkpoint inhibitors in bone metastasis: clinical challenges, toxicities, and mechanisms. J. Bone Oncol.. 2023, 43: 100505.

[55] Sun, C., Mezzadra, R. & Schumacher, T. N. Regulation and function of the PD-L1 checkpoint. Immunity 48, 434–452 (2018).

[56] Bader JEet al. . Obesity induces PD-1 on macrophages to suppress anti-tumour immunity. Nature. 2024, 630968-975.

[57] Wang Ket al. . PD-1 blockade inhibits osteoclast formation and murine bone cancer pain. J. Clin. Invest.. 2020, 130: 3603.

[58] Zuo H, Wan Y. Inhibition of myeloid PD-L1 suppresses osteoclastogenesis and cancer bone metastasis. Cancer Gene Ther.. 2022, 291342-1354.

[59] Ren Y, Bäcker H, Müller M, Kienzle A. The role of myeloid derived suppressor cells in musculoskeletal disorders. Front. Immunol.. 2023, 14: 1139683.

[60] Wang L, Lan J, Tang J, Luo N. MCP-1 targeting: shutting off an engine for tumor development. Oncol. Lett.. 2021, 2326.

[61] del Fresno C, Sancho D. Myeloid cells in sensing of tissue damage. Curr. Opin. Immunol.. 2021, 6834-40.

[62] Reyes Met al. . White adipose tissue-infiltrated CD11b⁺ myeloid cells are a source of S100A4, a new potential marker of hepatic damage. Eur. J. Endocrinol.. 2021, 184: 533-541.

[63] Devêvre EFet al. . Profiling of the three circulating monocyte subpopulations in human obesity. J. Immunol.. 2015, 194: 3917-3923.

[64] Friedrich Ket al. . Perturbation of the monocyte compartment in human obesity. Front. Immunol.. 2019, 10: 458434.

[65] Krinninger Pet al. . Peripheral monocytes of obese women display increased chemokine receptor expression and migration capacity. J. Clin. Endocrinol. Metab.. 2014, 992500-2509.

[66] Caetano-Lopes J, Canhão H, Fonseca JE. Osteoimmunology—the hidden immune regulation of bone. Autoimmun. Rev.. 2009, 8: 250-255.

[67] del Fattore A, Teti A. The tight relationship between osteoclasts and the immune system. Inflamm. Allergy Drug Targets. 2012, 11: 181-187.

[68] Veldhuis-Vlug, A. G. & Rosen, C. J. Clinical implications of bone marrow adiposity. J. Intern. Med.283, 121–139 (2018).

[69] Austin MJ, Kalampalika F, Cawthorn WP, Patel B. Turning the spotlight on bone marrow adipocytes in haematological malignancy and non-malignant conditions. Br. J. Haematol.. 2023, 201: 605.

[70] Caers Jet al. . Neighboring adipocytes participate in the bone marrow microenvironment of multiple myeloma cells. Leukemia. 2007, 211580-1584.

[71] Shafat MSet al. . Leukemic blasts program bone marrow adipocytes to generate a protumoral microenvironment. Blood. 2017, 129: 1320-1332.

[72] Costa S, Fairfield H, Reagan MRMR. Inverse correlation between trabecular bone volume and bone marrow adipose tissue in rats treated with osteoanabolic agents. Bone. 2019, 123: 211-223.

[73] Costa Set al. . Sclerostin antibody increases trabecular bone and bone mechanical properties by increasing osteoblast activity damaged by whole-body irradiation in mice. Bone. 2021, 147. 115918

[74] Nardone V, D’Asta F, Brandi ML. Pharmacological management of osteogenesis. Clinics. 2014, 69: 438.

[75] Ominsky MS, Boyce RW, Li X, Ke HZ. Effects of sclerostin antibodies in animal models of osteoporosis. Bone. 2017, 9663-75.

[76] Li Xet al. . Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis. J. Bone. 2009, 24: 578-588

[77] Jilka RL. Molecular and cellular mechanisms of the anabolic effect of intermittent PTH. Bone. 2007, 40: 1434-1446.

[78] Sandovici I, Morais T, Constância M, Monteiro MP. Epigenetic changes associated with obesity-related metabolic comorbidities. J. Endocr. Soc.. 2025, 9: bvaf129.

[79] Dekkers KFet al. . Blood lipids influence DNA methylation in circulating cells. Genome Biol.. 2016, 17. 138

[80] Kasinska MA, Drzewoski J, Sliwinska A. Epigenetic modifications in adipose tissue—relation to obesity and diabetes. Arch. Med. Sci.. 2016, 121293-1301.

[81] Zhou C, Gao Y, Ding P, Wu T, Ji G. The role of CXCL family members in different diseases. Cell Death Discov.. 2023, 9: 1-12.

[82] Hardaway AL, Herroon MK, Rajagurubandara E, Podgorski I. Marrow adipocyte-derived CXCL1 and CXCL2 contribute to osteolysis in metastatic prostate cancer. Clin. Exp. Metastasis. 2015, 32: 353-368.

[83] Lotfi Net al. . Roles of GM-CSF in the pathogenesis of autoimmune diseases: an update. Front. Immunol.. 2019, 10: 1265.

[84] Yu Det al. . CCL3 in the bone marrow microenvironment causes bone loss and bone marrow adiposity in aged mice. JCI Insight. 2023, 8. e159107

[85] Kennedy Aet al. . Impact of macrophage inflammatory protein-1α deficiency on atherosclerotic lesion formation, hepatic steatosis, and adipose tissue expansion. PLoS. 2012, 7e31508.

[86] Chan PC, Lu CH, Chien HC, Tian YF, Hsieh PS. Adipose tissue-derived CCL5 enhances local pro-inflammatory monocytic MDSCs accumulation and inflammation via CCR5 receptor in high-fat diet-fed mice. Int. J. Mol. Sci.. 2022, 2314226.

[87] Wang Zet al. . Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockade. Nat. Med.. 2019, 25141-151.

[88] Bouxsein MLet al. . Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J. Bone. 2010, 25: 1468-1486

[89] Vignery A, Baron R. Dynamic histomorphometry of alveolar bone remodeling in the adult rat. Anat. Rec.. 1980, 196: 191-200.

[90] Dempster DWet al. . Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J. Bone. 2013, 28: 2-17

[91] Costa SN, Chlebek C, Rosen CJ. Isolation and characterization of primary bone marrow adipocytes in rodent models. Methods Mol. Biol.. 2025, 2885: 87-98.

[92] Yin Het al. . Protective role of ErbB3 signaling in myeloid cells during adaptation to cardiac pressure overload. J. Mol. Cell Cardiol.. 2020, 1521.

Funding

U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(RO1 AR073774)

U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI)(R01 HL136560)

RIGHTS & PERMISSIONS

The Author(s)